Cargando…
Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells
Ovarian cancer is the leading cause of mortality among all gynecological malignancies. Drug resistance is a cause of ovarian cancer recurrence and low rate of overall survival. There is a requirement for more effective treatment approaches. Cucurbitacin B (CuB) is an antineoplastic agent derived fro...
Autores principales: | Qu, Yingchun, Cong, Peifang, Lin, Chengjiang, Deng, Yihui, Li-Ling, Jesse, Zhang, Meixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494940/ https://www.ncbi.nlm.nih.gov/pubmed/28693146 http://dx.doi.org/10.3892/ol.2017.6148 |
Ejemplares similares
-
The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic pain
por: Park, Keun-Tae, et al.
Publicado: (2023) -
Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
por: Liu, Wen-Bei, et al.
Publicado: (2022) -
Cucurbitacin E Induces Autophagy-Involved Apoptosis in Intestinal Epithelial Cells
por: Song, Huapei, et al.
Publicado: (2020) -
Cucurbitacins: elucidation of their interactions with the cytoskeleton
por: Wang, Xiaojuan, et al.
Publicado: (2017) -
Pharmacokinetics and Biological Activity of Cucurbitacins
por: Delgado-Tiburcio, Eugenia Elisa, et al.
Publicado: (2022)